2022 annual financial data
Kymera Therapeutics 2022 Operating margin
Kymera Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -344.37%.
Operating income was -161,256,000 USD and net income was -154,808,000 USD.
Operating cash flow was -153,085,000 USD.
Get free Kymera Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 46,826,000 USD
- Operating income
- -161,256,000 USD
- Net income
- -154,808,000 USD
- Operating cash flow
- -153,085,000 USD